HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroto Katoh Selected Research

iminobiotin

1/2022Antibody mimetic drug conjugate manufactured by high-yield Escherichia coli expression and non-covalent binding system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroto Katoh Research Topics

Disease

21Neoplasms (Cancer)
10/2022 - 11/2006
6Stomach Neoplasms (Stomach Cancer)
10/2022 - 01/2017
3Neoplasm Metastasis (Metastasis)
10/2022 - 02/2017
3Carcinogenesis
01/2022 - 02/2017
2Autoimmune Diseases (Autoimmune Disease)
10/2020 - 03/2013
2Squamous Cell Carcinoma of Head and Neck
01/2019 - 02/2017
2Prostatic Neoplasms (Prostate Cancer)
03/2011 - 11/2010
2Hepatocellular Carcinoma (Hepatoma)
11/2007 - 11/2006
1Cholangiocarcinoma
10/2022
1Acquired Immunodeficiency Syndrome (AIDS)
01/2022
1Meningioma (Meningiomas)
01/2022
1Chromosomal Instability (Chromosome Stability)
01/2022
1Hypoxia (Hypoxemia)
11/2021
1Interstitial Cystitis (Interstitial Cystitis, Chronic)
01/2019
1Inflammation (Inflammations)
01/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2019
1Adenocarcinoma
11/2017
1Metrorrhagia (Spotting)
08/2017
1Mitochondrial Diseases (Mitochondrial Disease)
05/2017
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
11/2006

Drug/Important Bio-Agent (IBA)

5Biological ProductsIBA
01/2022 - 11/2007
5DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2017
5Proteins (Proteins, Gene)FDA Link
10/2020 - 03/2011
3Transcription Factors (Transcription Factor)IBA
01/2022 - 11/2010
3AntigensIBA
10/2020 - 01/2017
2Immune Checkpoint InhibitorsIBA
01/2022 - 02/2017
2AntibodiesIBA
10/2020 - 01/2017
2Formaldehyde (Formol)FDA Link
01/2020 - 02/2017
2RNA (Ribonucleic Acid)IBA
01/2019 - 11/2016
2Biomarkers (Surrogate Marker)IBA
02/2018 - 11/2017
2Pharmaceutical PreparationsIBA
11/2016 - 03/2009
2beta CateninIBA
11/2007 - 11/2006
1Aspartate-tRNA LigaseIBA
10/2022
1Cadherins (E-Cadherin)IBA
10/2022
1Interferon-gamma (Interferon, gamma)IBA
10/2022
1Nucleic AcidsIBA
10/2022
1silicon phthalocyanineIBA
01/2022
1human ERBB2 proteinIBA
01/2022
1iminobiotinIBA
01/2022
1Forkhead Box Protein M1IBA
01/2022
1AcidsIBA
01/2022
1Eosine Yellowish-(YS) (Eosin)IBA
01/2022
1Hematoxylin (Haematoxylon)IBA
01/2022
1NucleotidesIBA
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1ApelinIBA
11/2021
1RibonucleoproteinsIBA
10/2020
1AutoantigensIBA
10/2020
1Cell-Free Nucleic AcidsIBA
01/2020
1Small Interfering RNA (siRNA)IBA
01/2019
1MDS1 and EVI1 Complex Locus ProteinIBA
01/2019
1GlypicansIBA
11/2017
1pyruvate dehydrogenase kinase 4IBA
05/2017
1xanthohumolIBA
04/2017
1Valosin Containing ProteinIBA
04/2017
1Chalcone (Benzalacetophenone)IBA
04/2017
1ParaffinIBA
02/2017
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2017
1GlycosaminoglycansIBA
01/2017
1LigandsIBA
11/2016
1Oncogene Proteins (Oncogene Protein)IBA
03/2011
1TamoxifenFDA LinkGeneric
03/2009
1Nonsense Codon (Nonsense Mutation)IBA
11/2006

Therapy/Procedure

5Therapeutics
10/2022 - 11/2016
3Immunotherapy
10/2020 - 01/2017
1Investigational Therapies (Experimental Therapy)
03/2013